Search research articles
Contact Us
Filters
Showing results (391-400 of 408) with videos related to
Page
of 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
Practical Radiation Oncology
|
January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma
Andrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Cancer Letters
|
June 7, 2024
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression
Tianhong Pan, Fengshuo Liu, Xiaoxin Hao, et al.
Clinical Sarcoma Research
|
January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
BMJ Supportive & Palliative Care
|
June 6, 2024
Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic
Minsoo Kim, Jose Alberto Maldonado, Prasamsa Pandey, et al.
Cancer
|
August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
Andrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Mbio
|
February 6, 2014
A broadly implementable research course in phage discovery and genomics for first-year undergraduate students
Tuajuanda C Jordan, Sandra H Burnett, Susan Carson, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 408) with videos related to
Sort By:
Page
of 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes
Ryan A Denu, Richard K Yang, Alexander J Lazar, et al.
Practical Radiation Oncology
|
January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma
Andrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Cancer Letters
|
June 7, 2024
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression
Tianhong Pan, Fengshuo Liu, Xiaoxin Hao, et al.
Clinical Sarcoma Research
|
January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
BMJ Supportive & Palliative Care
|
June 6, 2024
Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic
Minsoo Kim, Jose Alberto Maldonado, Prasamsa Pandey, et al.
Cancer
|
August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
Andrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Mbio
|
February 6, 2014
A broadly implementable research course in phage discovery and genomics for first-year undergraduate students
Tuajuanda C Jordan, Sandra H Burnett, Susan Carson, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Page
of 41